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Hereditary hemochromatosis (HH) is a prevalent, po-
tentially fatal disorder of iron metabolism hallmarked
by intestinal hyperabsorption of iron, hyperferremia,
and hepatic iron overload. In both humans and mice,
type I HH is associated with mutations in the broadly
expressed HFE/Hfe gene. To identify where Hfe acts
to prevent HH, we generated mice with tissue-spe-
cificHfe ablations. This work demonstrates that local
Hfe expression in hepatocytes serves to maintain
physiological iron homeostasis, answering a long-
standing question in medicine and explaining earlier
clinical observations.INTRODUCTION
Iron is essential for fundamental metabolic processes in cells and
organisms. Regulation of systemic iron homeostasis evolved to
maintain a plasma iron concentration that secures adequate
supplies while preventing organ iron overload. The homeostatic
system must react to signals from pathways that consume iron
(e.g., erythropoiesis) and send signals to cells that supply iron
(e.g., duodenal enterocytes, which absorb iron from the diet;
macrophages, which recycle iron from senescent erythrocytes;
andhepatocytes,which are themajor iron storage site) (Andrews,
2000). The small hepatic peptide hormone hepcidin (Hamp, or
LEAP1) (Krause et al., 2000; Park et al., 2001) orchestrates these
iron fluxes and controls the amount of available extracellular iron
by interacting with the iron exporter ferroportin (Nemeth et al.,
2004); binding of hepcidin induces ferroportin internalization
and degradation (Nemeth et al., 2004).
Systemic iron homeostasis is disrupted in the common iron
overload disorder hereditary hemochromatosis (HH) (for review,
see Andrews, 1999). HH is most frequently caused by mutations
in the HFE/Hfe gene. Mice homozygous with respect to an HFE
null allele or the orthologous murine Hfe mutation recapitulate
the HH phenotype observed in humans, confirming that HH
arises from a loss of Hfe function (Zhou et al., 1998; Levy et al.,
1999). Since the discovery of the HFE gene (Feder et al., 1996),
different models have been proposed to explain how HFE/HfeCmalfunction causes increased intestinal iron absorption, hepatic
iron overload, and relative iron deficiency in macrophages, the
main features of HH. Lack of functional Hfe in intestinal cells
was initially suggested to affect serosal iron uptake mediated
by transferrin receptor 1 (TfR1) and to increase intestinal iron
transporter expression (Fleming et al., 1999). However, entero-
cyte-specific Hfe ablation in mice recently excluded a primary
role for duodenal Hfe in the pathogenesis of HH, as hepatic
and plasma iron parameters as well as Hamp mRNA expression
remained unaffected in this mouse model and failed to recapitu-
late any aspect of the HH phenotype in mice (Vujic Spasic et al.,
2007). Inappropriately low HampmRNA expression is largely ac-
cepted to play a central role in the pathogenesis of HH (Bridle
et al., 2003; Muckenthaler et al., 2003; Nicolas et al., 2003). How-
ever, it is unclear how Hfe affects HampmRNA expression in the
liver and whether Hfe does so via its expression in hepatocytes,
livermacrophages, and/or other cell types. To answer this funda-
mental question for the understanding of Hfe function and HH,
we generated mice with tissue-specific ablations of Hfe. We
find that hepatocytic, but not macrophage, Hfe plays the key
role in preventing HH.RESULTS AND DISCUSSION
Generation of HfeLysMCre and HfeAlfpCre Mutant Mice
We previously generated a mouse line carrying a floxed Hfe
allele, in which exons 3–5 are flanked with two loxP sites
(Figure 1A) (Herrmann et al., 2004). To generate mice lacking
the Hfe allele specifically in hepatocytes (HfeAlfpCre) or macro-
phages (HfeLysMCre), we crossed mice carrying the floxed Hfe
allele with mice expressing Cre recombinase under the control
of the hepatocyte-specific albumin promoter (Kellendonk et al.,
2000) or the lysozymeM promoter that is active in macrophages,
including Kupffer cells (the resident macrophages of the liver)
(Clausen et al., 1999), respectively. HfeLysMCre and HfeAlfpCre
mutant mice are viable and show no overt physical or behavioral
abnormalities. Southern blot analysis of genomic DNA from
different tissues of HfeAlfpCre(+) mutant mice showed selective
recombination in the liver and in isolated hepatocytes (Figure 1B).
InHfeLysMCre(+) mutant mice, theHfe allele was efficiently recom-
bined in bone marrow-derived (BMDM) and peritoneal macro-
phages (PMF) (Figure 1C). In addition, low-level recombinationell Metabolism 7, 173–178, February 2008 ª2008 Elsevier Inc. 173
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Hemochromatosis in HfeAlfpCre Mutant Micewas apparent in lung and heart—presumably derived from the
resident macrophages in these tissues (Figure 1C).
Hepatic Iron Overload in HfeAlfpCre(+) Mutant Mice
HH patients are characterized by elevated plasma iron content,
increased transferrin saturation, and hepatic iron overload (Flem-
ing and Sly, 2002). Similar anomalies of systemic iron metabo-
lism are also observed inmousemodels with constitutiveHfe de-
ficiency (Fleming et al., 2001; Vujic Spasic et al., 2007; Zhou
et al., 1998). We thus compared the hepatic iron content of
HfeAlfpCre(+) and HfeLysMCre(+) mice with age- and sex-matched
Cre() littermates, mice derived from the same original line
with constitutive Hfe deficiency (Hfe/), and wild-type controls
(Herrmann et al., 2004; Vujic Spasic et al., 2007).
Hfe/ males and females deposited significantly more he-
patic iron than C57BL/6J control mice (Table 1; Figure 2A)
(Vujic Spasic et al., 2007). Importantly, hepatic iron accumula-
tion in HfeAlfpCre(+) mice of both sexes recapitulated the iron
overload of Hfe/ mice (Table 1), with iron accumulating174 Cell Metabolism 7, 173–178, February 2008 ª2008 Elsevier Inc.predominantly in parenchymal cells of the liver (Figure 2A). Fur-
thermore, hepatic iron levels in an unrelated AlfpCre-expressing
transgenic mouse line were unaffected in age- and sex-
matched controls (data not shown). Consistent with earlier ob-
servations (Nicolas et al., 2001; Viatte et al., 2005), Hfe/ mice
showed significantly reduced splenic iron content, another
hallmark of HH, which was reflected in HfeAlfpCre(+) mice (Table
1). By contrast, no changes in total nonheme iron content were
observed in HfeLysMCre(+) mice (Table 1). Importantly, splenic
iron distribution was comparable in all mouse lines analyzed
(Figure 2B), suggesting that Hfe ablation does not cause differ-
ential local iron distribution in the spleen that may not be
accounted for by measurements of total nonheme iron con-
tent. Finally, plasma iron levels and transferrin saturation were
comparably elevated in Hfe/ and HfeAlfpCre(+) mice, while
HfeLysMCre(+) mice were normal for all of the measured iron pa-
rameters (Table 1; Figure 2). Thus, Hfe deficiency in hepato-
cytes, but not in macrophages, fully recapitulates the murine
HH phenotype.Figure 1. Generation of HfeAlfpCre and HfeLysMCre Mutant Mice
(A) To generate mice with hepatocyte- and macrophage-specific Hfe ablation, mice carrying a floxed Hfe allele were crossed with mice expressing Cre recom-
binase under the control of the albumin promoter or the lysozyme M promoter, respectively. Cre-mediated excision of exons 3–5 generates an Hfe null allele.
Exons are depicted by numbered boxes; triangles indicate the loxP sites. The position of the probe used for Southern blot analysis is also indicated.
(B and C) The Hfe allele is efficiently recombined in hepatocytes of HfeAlfpCre(+) mice and in macrophages of HfeLysMCre(+) mice. Genomic DNA from C57BL/6J,
Hfe/, HfeAlfpCre (B), and HfeLysMCre (C) mice was prepared from organs and cells as indicated, digested with SacI, and Southern blotted with a DNA probe
directed against intron 5. The upper band corresponds to the floxed Hfe allele, and the lower band corresponds to the recombined allele. Three independent
liver and hepatocyte preparations of HfeAlfpCre(+) mice are shown in (B).
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Hemochromatosis in HfeAlfpCre Mutant MiceHamp mRNA Expression Is Inappropriately
Low in HfeAlfpCre(+) Mutant Mice
In HHpatients andmousemodels of hemochromatosis,HFE/Hfe
deficiency is accompanied by inappropriately low expression of
the hepatic iron hormone Hamp that fails to be increased in re-
sponse to elevated liver iron levels (Bridle et al., 2003; Muck-
enthaler et al., 2003; Nicolas et al., 2003). We analyzed Hamp
mRNA levels in Hfe/, HfeAlfpCre, and HfeLysMCre female mice
by quantitative real-time PCR. Hamp mRNA expression was
significantly diminished in Hfe/ (2.03-fold; p < 0.0002) and
HfeAlfpCre(+) (2.95-fold; p < 0.003) mice (Figure 3). Again, Hamp
mRNA expression inHfeLysMCre(+) mice remained unaltered (Fig-
ure 3), consistent with the unchanged hepatic and plasma iron
parameters in this mouse strain (Table 1; Figure 2).
Our finding that HfeLysMCre(+) mice show normal iron metabo-
lism parameters is consistent with observations in wild-type
mice subjected to pharmacological macrophage depletion,
which display normal hepatic iron levels and an intact hepcidin
response upon iron challenge (Lou et al., 2005; Montosi et al.,
2005). Conversely, reciprocal bone marrow transplantation ex-
periments between wild-type and Hfe/ mice suggest a role
for macrophage Hfe in the regulation of splenic and liver iron
concentrations and Hamp mRNA expression (Makui et al.,
2005). Because systemic iron parameters remain unchanged in
HfeLysMCre(+) mice (Table 1; Figure 2; Figure 3), the possibility
that bone marrow effectors other than macrophages may ac-
count for these observations should be considered.
Hepatocyte-specific HfeAlfpCre(+) mutant mice fully recapitu-
late the phenotype observed in Hfe/ mice, with severe liver
iron accumulation, reduced splenic iron content, increased
transferrin saturation, and hyperferremia. These findings show
directly that Hfe must be expressed in hepatocytes to prevent
hemochromatosis. This result also explains previous clinical
studies demonstrating iron overload in HFE-wild-type recipients
of liver transplants when the donor organ was derived from
a C282Y homozygous HH patient (Crawford et al., 2004; Wigg
et al., 2003). Conversely, iron parameters returned to normal
when the liver of a healthy donor was transplanted into
a C282Y homozygous individual (Adams, 2003).COur data also show directly that hepatocytic Hfe is important
for appropriate Hamp mRNA expression. This finding supports
a model in which Hfe colocalizes in hepatocytes with two
other HH proteins, TfR2 and hemojuvelin (encoded by the gene
Hfe2), that also regulate hepcidin expression. Interaction of Hfe
with TfR2 has been previously reported (Goswami and Andrews,
2006). Whether hemojuvelin, a BMP coreceptor that controls
hepcidin expression via the Smad pathway (Babitt et al., 2006),
is part of the same complex remains to be investigated. Like-
wise, future studies need to address whether Hfe impinges on
the BMP/Smad pathway or whether other signaling pathways
are involved in controlling hepcidin expression via Hfe. Knowing
that Hfe acts in hepatocytes to regulate hepcidin expression rep-
resents a critical step toward understanding HH.EXPERIMENTAL PROCEDURES
Mice
Mice carrying the null or the floxed Hfe allele have been described previously
(Herrmann et al., 2004; Vujic Spasic et al., 2007). The floxed Hfe allele consists
of exons 3–5 flanked by loxP sites; constitutive, Cre-mediated excision of
these exons generates an Hfe null allele (Herrmann et al., 2004; Vujic Spasic
et al., 2007). Selective Hfe ablation in hepatocytes was achieved by crossing
mice with a floxed Hfe allele with AlfpCre transgenic mice raised on a
C57BL/6J genetic background (kindly provided by G. Schu¨tz, DKFZ), which
express Cre recombinase under the control of both mouse albumin regulatory
elements and the a-fetoprotein enhancers (Kellendonk et al., 2000). Selective
Hfe ablation in macrophages was achieved by crossing mice with a floxed Hfe
allele with LysMCre transgenic mice (kindly provided by I. Fo¨rster, Institut fu¨r
Umweltmedizinische Forschung, Heinrich-Heine-Universita¨t Du¨sseldorf, and
maintained on a C57BL/6J genetic background), which specifically express
Cre recombinase under the control of the murine lysozyme M promoter in
monocytes/macrophages (Clausen et al., 1999). Mice were genotyped by
PCR analysis of genomic DNA extracted from the tail tip as described previ-
ously (Vujic Spasic et al., 2007).
Cre-mediated excision of exons 3–5 in floxed Hfe alleles was assessed by
Southern blotting using SacI digestion of isolated genomic DNA and a probe
directed against Hfe intron 5. The probe (280 bp) was generated using the
primers 50-GAGTAGGAGAGTGTATTATTGG-30 and 50-ACAGACCAGAGATA
ACCATCC-30.
All mouse lines were maintained on a C57BL/6J genetic background. Mice
of both sexes were analyzed at 8–10 weeks of age. Age- and sex-matchedTable 1. Plasma Iron Parameters and Nonheme Liver and Spleen Iron Content Are Altered in Hfe/ and HfeAlfpCre(+) Mutant Mice
Strain Sex n Liver Iron (mg/g) Spleen Iron (mg/g) Plasma Iron (mg/dl) Tf Saturation (%) UIBC (mg/dl)
C57BL/6J male 8 246.0 ± 69.9 1384.5 ± 606.6 134.2 ± 26.5 24.7 ± 6.1 395.3 ± 73.9
Hfe/ male 8 1474.5 ± 178.1** 666.0 ± 159.5** 195.4 ± 30.4** 40.9 ± 8.5* 269.7 ± 57.4*
C57BL/6J female 6 425.0 ± 170.9 2942.6 ± 836.8 182.9 ± 44.2 28.6 ± 6.2 403.3 ± 95.0
Hfe/ female 6 1375.5 ± 324.8** 1345.8 ± 390.7** 371.1 ± 87.7* 61.1 ± 9.1* 196.4 ± 57.5*
HfeAlfpCre() male 9 283.7 ± 117.5 1760.4 ± 894.8 188.6 ± 66.8 30.4 ± 6.4 419.2 ± 40.9
HfeAlfpCre(+) male 8 1350.5 ± 255.9** 770.8 ± 143.8** 300.9 ± 76.4** 44.0 ± 6.1* 359.7 ± 16.3*
HfeAlfpCre() female 11 566.2 ± 154.6 2332.0 ± 848.1 236.1 ± 55.1 42.7 ± 9.9 331.5 ± 105.5
HfeAlfpCre(+) female 10 1264.8 ± 332.7** 1339.1 ± 531.1** 348.2 ± 77.6* 52.0 ± 8.8* 321.5 ± 70.2y
HfeLysMCre() male 9 284.4 ± 28.6 1242.0 ± 218.3 147.2 ± 29.8 28.3 ± 5.7 376.8 ± 57.1
HfeLysMCre(+) male 9 259.0 ± 44.1y 1430.0 ± 387.7y 131.3 ± 23.8y 25.2 ± 3.1y 387.9 ± 7.9y
HfeLysMCre() female 7 252.0 ± 57.5 1703.8 ± 351.0 177.3 ± 37.3 30.9 ± 5.0 396.8 ± 46.5
HfeLysMCre(+) female 7 286.3 ± 38.8y 1526.3 ± 420.9y 158.8 ± 27.0y 29.2 ± 3.3y 381.1 ± 17.8y
Liver and spleen iron content (mg iron/g dry tissue), plasma iron content, transferrin (Tf) saturation, and unsaturated iron binding capacity (UIBC)
were determined in age- and sex-matched C57BL/6J wild-type, Hfe/, HfeAlfpCre, and HfeLysMCre mice. Data are shown as mean ± SD. *p < 0.05;
**p < 0.005; yp = not significant versus corresponding value listed above by Student’s t test.ell Metabolism 7, 173–178, February 2008 ª2008 Elsevier Inc. 175
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Hemochromatosis in HfeAlfpCre Mutant Micewild-type C57BL/6J, HfeAlfpCre(), and HfeLysMCre() littermates were used as
controls throughout the study. All micewere housed in the EMBL animal facility
under a constant light-dark cycle, maintained on a standard mouse diet con-
taining 225 mg/kg iron (Teklad 2018 S, Harlan Winkelmann), and allowed ad
libitum access to food and water. Mice were euthanized by CO2 inhalation.
Heparinized blood was collected by cardiac puncture. All mouse breeding
and animal experiments were approved by and conducted in compliance
with the guidelines of the EMBL Institutional Animal Care and Use Committee.
Isolation of Peritoneal and Bone Marrow-Derived Macrophages
HfeLysMCremice (n = 5 Cre() and 5 Cre(+) mice) were injected intraperitoneally
with 1.5ml of 2.98%water-solubilized thioglycolatemedium (Sigma), and cells
were harvested after 4 days by peritoneal lavage using cold PBS. After centri-
fugation, the cell pellet was resuspended in RPMI 1640medium supplemented
with 10% FCS (Invitrogen). Freshly isolated peritoneal macrophages were
seeded at a concentration of 107 cells per 100 mm dish in RPMI medium
with 10% FCS (Invitrogen). The cells were allowed to adhere to the plastic sur-
face for 3–4 hr, and nonadherent cells were removed by exchanging the me-
dium. After overnight incubation at 37C in a 5% CO2 atmosphere, cells
were collected and used for DNA isolation.
Bone marrow cells were harvested from HfeLysMCre mice (n = 5 Cre() and
5 Cre(+) mice) by flushing the femurs and tibiae of mice with HBSS. Freshly176 Cell Metabolism 7, 173–178, February 2008 ª2008 Elsevier Inc.isolated bone marrow-derived macrophages were seeded at a concentration
of approximately 107 cells per 100mmdish in RPMI 1640medium supplemen-
ted with 10% FCS (Invitrogen) and mouse CSF (100 ng/ml, Sigma-Aldrich,
Inc.) and cultured for 7 days, with medium exchanged every 2–3 days.
The purity of peritoneal and bone marrow-derived macrophages was esti-
mated by FACS analysis to be 80% and 90%, respectively, using F4/80 anti-
body (Pharmingen).
Liver Cell Isolation
Single-cell suspensions were prepared from livers of HfeAlfpCre mice using
an in situ perfusion method (Lichtman et al., 1998). Briefly, livers were per-
fused with 0.02% collagenase (Sigma-Aldrich, Inc.) in warm HBSS, removed,
sliced, and filtered via a 100 mmmesh. The resultant suspension was pelleted
for 30minat 4C to allow separationof hepatocytes fromnonparenchymal cells.
The purity of isolated hepatocytes was 95%, as determined by morphology
and May-Gru¨nwald-Giemsa staining of the cells.
Iron Assays
Plasma iron concentrations were assayed using an iron kit (Thermo Electron
GmbH) in a 96-well format using a serial dilution of iron atomic absorption stan-
dard solution (1000 mg/ml iron in HCl, Sigma-Aldrich, Inc.). Unsaturated iron
binding capacity (UIBC) was measured using a UIBC kit (Biolabo) accordingFigure 2. Hepatic and Splenic Iron Content in Hfe/, HfeAlfpCre, and HfeLysMCre Mutant Mice
Perls staining of liver sections (A) (original magnification 320) and spleen sections (B) (original magnification 310) from C57BL/6J, Hfe/, HfeAlfpCre, and
HfeLysMCre female mice. Nonheme iron stains brown. wp, white pulp; rp, red pulp zone of the spleen.
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Hemochromatosis in HfeAlfpCre Mutant Miceto the manufacturer’s instructions. Transferrin saturation was calculated using
the formula Fe/(Fe + UIBC) 3 100.
Nonheme iron content of liver and spleen tissues was measured as de-
scribed previously (Torrance and Bothwell, 1968). For staining of hepatic
and splenic nonheme ferrous iron, 3,3-diaminobenzidine tetrahydrochloride
(DAB)-enhanced Perls Prussian blue staining was applied. Snap-frozen livers
and spleens of C57BL/6J, Hfe/, HfeAlfpCre, and HfeLysMCre male and female
mice were cut into 5 mm sections and mounted on slides for staining with Perls
solution (4%HCl and 4%potassium ferrocyanide, 1:1) at room temperature for
60 min. Subsequently, slides were incubated for 15 min in DAB and then im-
mersed in 0.015% H2O2 in DAB. All microscopy was performed using a Zeiss
Axioskop 2 microscope. Digital images were captured using a DC500 camera
(Leica) and processed with Adobe Photoshop 7.0.1 software.
Figure 3. Hepatic Hamp1mRNAExpression inHfe/,HfeAlfpCre, and
HfeLysMCre Mutant Mice
Hamp1 mRNA expression was measured by quantitative real-time PCR in
C57BL/6J, Hfe/, HfeAlfpCre, and HfeLysMCre female mice. The number of
mice analyzed in each group is given in brackets to the right of the genotype.
Mean Hamp1 mRNA expression in wild-type or Cre() control mice was set to
100%; all other data are expressed in relation to this. Data are shown as mean
values ± SD. *p < 0.05; **p < 0.005 by Student’s t test.RNA Extraction, Reverse Transcription, and Real-Time PCR
Total RNA was isolated using TRI Reagent (MRC Inc.), and 2 mg of total RNA
was reverse transcribed using Revertaid HMinus M-MuLV Reverse Transcrip-
tase (Fermentas) following the manufacturer’s instructions. Quantitative real-
time PCR was carried out with 20 ml reaction volumes using SYBR green I
dye on an ABI Prism 7500 (Applied Biosystems). Primers were designed to
specifically amplify Hamp1 (50-ATACCAATGCAGAAGAGAAGG-30 and 50-AAC
AGATACCACACTGGGAA-30) and glyceraldehyde 3-phosphate dehydroge-
nase (Gapdh) (50-GTGGAGATTGTTGCCATCAACGA-30 and 50-CCCATTCTC
GGCCTTGACTGT-30 ) sequences. The mRNA abundance of Hamp1 was
calculated relative to the expression of Gapdh. Data were analyzed using
a mathematical model based on correction for exact PCR efficiencies.Statistical Analysis
Data are shown asmean values ± SD. Statistical analysis was performed using
Student’s t test (two-tailed, unequal variance), and p values < 0.05 (*) and
< 0.005 (**) are considered significant and highly significant, respectively.ACKNOWLEDGMENTS
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